Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9495462 | 1.00 | PDCD1 (0.30) | PDCD1CD274 | |
| SCHEMBL30222726 | 1.00 | PDCD1 (0.30) | PDCD1CD274 | |
| SCHEMBL30140781 | 0.89 | L3MBTL1 (0.35) | — | |
| SCHEMBL8370882 | 0.83 | KDM4E (0.34) | — | |
| SCHEMBL2171319 | 0.82 | FAAH (0.40) | — | |
| SCHEMBL20163435 | 0.79 | — | — | |
| SCHEMBL2035767 | 0.77 | — | — | |
| SCHEMBL2997778 | 0.75 | — | — | |
| SCHEMBL9614617 | 0.75 | — | — | |
| SCHEMBL22774139 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260077050-A1 | PROTAC DEGRADERS OF SARS-COV-2 MAIN PROTEASE | TEXAS A & M UNIV SYS (US) | 2026-03-19 | — | — | US | disclosed |
| EP-4598914-A1 | PROTACS USEFUL AGAINST THE MAIN PROTEASE SARS-COV-2 | Tocris Cookson Limited (GB) | 2025-08-13 | — | — | EP | disclosed |
| EP-4380920-A1 | INHIBITORS FOR CORONAVIRUSES | Cocrystal Pharma, Inc. (US) | 2024-06-12 | — | — | EP | disclosed |
| WO-2024074848-A1 | PROTACS USEFUL AGAINST THE MAIN PROTEASE SARS-COV-2 | TOCRIS COOKSON LIMITED (GB) | 2024-04-11 | — | — | WO | disclosed |
| WO-2023014758-A1 | INHIBITORS FOR CORONAVIRUSES | COCRYSTAL PHARMA, INC. (US) | 2023-02-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260077050-A1 | PROTAC DEGRADERS OF SARS-COV-2 MAIN PROTEASE | UBE3C, PSMC3, PSMC4 | PDCD1 1558/4885CD274 1535/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.